Table of Contents

1 Report Overview
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Neutral Alternative Protein Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Analysis by Types
2.1 Overall Market Performance(Volume)
2.1.1 Plant Protein (Volume)
2.1.2 Insect Protein (Volume)
2.1.3 Algae Protein (Volume)
2.1.4 Others (Volume)
2.2 Overall Market Performance(Value)
2.2.1 Plant Protein (Value)
2.2.2 Insect Protein (Value)
2.2.3 Algae Protein (Value)
2.2.4 Others (Value)
3 Product Application Market
3.1 Overall Market Performance (Volume)
3.1.1 Food & Beverage (Volume)
3.1.2 Healthcare product (Volume)
4 Manufacturers Profiles/Analysis
4.1 Kerry Group
4.1.1 Kerry Group Profiles
4.1.2 Kerry Group Product Information
4.1.3 Kerry Group Neutral Alternative Protein Business Performance
4.1.4 Kerry Group Neutral Alternative Protein Business Development and Market Status
4.2 Cargill
4.2.1 Cargill Profiles
4.2.2 Cargill Product Information
4.2.3 Cargill Neutral Alternative Protein Business Performance
4.2.4 Cargill Neutral Alternative Protein Business Development and Market Status
4.3 Archer Daniels Midland Company
4.3.1 Archer Daniels Midland Company Profiles
4.3.2 Archer Daniels Midland Company Product Information
4.3.3 Archer Daniels Midland Company Neutral Alternative Protein Business Performance
4.3.4 Archer Daniels Midland Company Neutral Alternative Protein Business Development and Market Status
4.4 Glanbia
4.4.1 Glanbia Profiles
4.4.2 Glanbia Product Information
4.4.3 Glanbia Neutral Alternative Protein Business Performance
4.4.4 Glanbia Neutral Alternative Protein Business Development and Market Status
4.5 CHS
4.5.1 CHS Profiles
4.5.2 CHS Product Information
4.5.3 CHS Neutral Alternative Protein Business Performance
4.5.4 CHS Neutral Alternative Protein Business Development and Market Status
4.6 Tereos Syral
4.6.1 Tereos Syral Profiles
4.6.2 Tereos Syral Product Information
4.6.3 Tereos Syral Neutral Alternative Protein Business Performance
4.6.4 Tereos Syral Neutral Alternative Protein Business Development and Market Status
4.7 CP Kelco
4.7.1 CP Kelco Profiles
4.7.2 CP Kelco Product Information
4.7.3 CP Kelco Neutral Alternative Protein Business Performance
4.7.4 CP Kelco Neutral Alternative Protein Business Development and Market Status
4.8 Davisco
4.8.1 Davisco Profiles
4.8.2 Davisco Product Information
4.8.3 Davisco Neutral Alternative Protein Business Performance
4.8.4 Davisco Neutral Alternative Protein Business Development and Market Status
4.9 Meelunie
4.9.1 Meelunie Profiles
4.9.2 Meelunie Product Information
4.9.3 Meelunie Neutral Alternative Protein Business Performance
4.9.4 Meelunie Neutral Alternative Protein Business Development and Market Status
4.10 Danisco (DuPont)
4.10.1 Danisco (DuPont) Profiles
4.10.2 Danisco (DuPont) Product Information
4.10.3 Danisco (DuPont) Neutral Alternative Protein Business Performance
4.10.4 Danisco (DuPont) Neutral Alternative Protein Business Development and Market Status
4.11 MGP Ingredient
4.12 Taj Agro Product
4.13 Glico Nutrition
5 Market Performance for Manufacturers
5.1 China Neutral Alternative Protein Sales (K Units) and Market Share by Manufacturers 2014-2020
5.2 China Neutral Alternative Protein Revenue (M USD) and Market Share by Manufacturers 2014-2020
5.3 China Neutral Alternative Protein Price (USD/Unit) of Manufacturers 2014-2020
5.4 China Neutral Alternative Protein Gross Margin of Manufacturers 2014-2020
5.5 Market Concentration
6 Regions Market Performance for Manufacturers
6.1 South China Market Performance for Manufacturers
6.1.1 South China Neutral Alternative Protein Sales (K Units) and Share of Manufacturers 2014-2020
6.1.2 South China Neutral Alternative Protein Revenue (M USD) and Share of Manufacturers 2014-2020
6.1.3 South China Neutral Alternative Protein Price (USD/Unit) of Manufacturers 2014-2020
6.1.4 South China Neutral Alternative Protein Gross Margin of Manufacturers 2014-2020
6.1.5 Market Concentration
6.2 East China Market Performance for Manufacturers
6.2.1 East China Neutral Alternative Protein Sales (K Units) and Share of Manufacturers 2014-2020
6.2.2 East China Neutral Alternative Protein Revenue (M USD) and Share of Manufacturers 2014-2020
6.2.3 East China Neutral Alternative Protein Price (USD/Unit) of Manufacturers 2014-2020
6.2.4 East China Neutral Alternative Protein Gross Margin of Manufacturers 2014-2020
6.2.5 Market Concentration
6.3 Southwest China Market Performance for Manufacturers
6.3.1 Southwest China Neutral Alternative Protein Sales (K Units) and Share of Manufacturers 2014-2020
6.3.2 Southwest China Neutral Alternative Protein Revenue (M USD) and Share of Manufacturers 2014-2020
6.3.3 Southwest China Neutral Alternative Protein Price (USD/Unit) of Manufacturers 2014-2020
6.3.4 Southwest China Neutral Alternative Protein Gross Margin of Manufacturers 2014-2020
6.3.5 Market Concentration
6.4 Northeast China Market Performance for Manufacturers
6.4.1 Northeast China Neutral Alternative Protein Sales (K Units) and Share of Manufacturers 2014-2020
6.4.2 Northeast China Neutral Alternative Protein Revenue (M USD) and Share of Manufacturers 2014-2020
6.4.3 Northeast China Neutral Alternative Protein Price (USD/Unit) of Manufacturers 2014-2020
6.4.4 Northeast China Neutral Alternative Protein Gross Margin of Manufacturers 2014-2020
6.4.5 Market Concentration
6.5 North China Market Performance for Manufacturers
6.5.1 North China Neutral Alternative Protein Sales (K Units) and Share of Manufacturers 2014-2020
6.5.2 North China Neutral Alternative Protein Revenue (M USD) and Share of Manufacturers 2014-2020
6.5.3 North China Neutral Alternative Protein Price (USD/Unit) of Manufacturers 2014-2020
6.5.4 North China Neutral Alternative Protein Gross Margin of Manufacturers 2014-2020
6.5.5 Market Concentration
6.6 Central China Market Performance for Manufacturers
6.6.1 Central China Neutral Alternative Protein Sales (K Units) and Share of Manufacturers 2014-2020
6.6.2 Central China Neutral Alternative Protein Revenue (M USD) and Share of Manufacturers 2014-2020
6.6.3 Central China Neutral Alternative Protein Price (USD/Unit) of Manufacturers 2014-2020
6.6.4 Central China Neutral Alternative Protein Gross Margin of Manufacturers 2014-2020
6.6.5 Market Concentration
6.7 Northwest China Market Performance for Manufacturers
6.7.1 Northwest China Neutral Alternative Protein Sales (K Units) and Share of Manufacturers 2014-2020
6.7.2 Northwest China Neutral Alternative Protein Revenue (M USD) and Share of Manufacturers 2014-2020
6.7.3 Northwest China Neutral Alternative Protein Price (USD/Unit) of Manufacturers 2014-2020
6.7.4 Northwest China Neutral Alternative Protein Gross Margin of Manufacturers 2014-2020
6.7.5 Market Concentration
7 China Neutral Alternative Protein Market Performance (Sales Point)
7.1 China Neutral Alternative Protein Sales (K Units) and Market Share by Regions 2014-2020
7.2 China Neutral Alternative Protein Revenue (M USD) and Market Share by Regions 2014-2020
7.3 China Neutral Alternative Protein Price (USD/Unit) by Regions 2014-2020
7.4 China Neutral Alternative Protein Gross Margin by Regions 2014-2020
8 Development Trend for Regions (Sales Point)
8.1 China Neutral Alternative Protein Sales and Growth, Sales Value and Growth Rate2014-2020
8.2 South China Neutral Alternative Protein Sales and Growth, Sales Value and Growth Rate2014-2020
8.3 East China Neutral Alternative Protein Sales and Growth, Sales Value and Growth Rate2014-2020
8.4 Southwest China Neutral Alternative Protein Sales and Growth, Sales Value and Growth Rate2014-2020
8.5 Northeast China Neutral Alternative Protein Sales and Growth, Sales Value and Growth Rate2014-2020
8.6 North China Neutral Alternative Protein Sales and Growth, Sales Value and Growth Rate2014-2020
8.7 Central China Neutral Alternative Protein Sales and Growth, Sales Value and Growth Rate2014-2020
8.8 Northwest China Neutral Alternative Protein Sales and Growth, Sales Value and Growth Rate2014-2020
9 Upstream Source, Technology and Cost
9.1 Upstream Source
9.2 Technology
9.3 Cost
10 Channel Analysis
10.1 Market Channel
10.2 Distributors
11 Consumer Analysis
11.1 Food & Beverage Industry
11.2 Healthcare product Industry
12 Market Forecast 2021-2026
12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2021-2026
12.1.1 China Neutral Alternative Protein Sales (K Units), Revenue (M USD) and Market Share by Regions 2021-2026
12.1.2 China Neutral Alternative Protein Sales (K Units) and Growth Rate 2021-2026
12.1.3 South China Neutral Alternative Protein Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.4 East China Neutral Alternative Protein Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.5 Southwest China Neutral Alternative Protein Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.6 Northeast China Neutral Alternative Protein Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.7 North China Neutral Alternative Protein Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.8 Central China Neutral Alternative Protein Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.9 Northwest China Neutral Alternative Protein Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.2 Sales (K Units) and Revenue (M USD) Forecast by Types 2021-2026
12.2.1 Overall Market Performance
12.2.2 Plant Protein
12.2.3 Insect Protein
12.2.4 Algae Protein
12.2.5 Others
12.3 Sales and Growth Rate Forecast by Application 2021-2026
12.3.1 Overall Market Performance
12.3.2 Food & Beverage
12.3.3 Healthcare product
12.4 Price (USD/Unit) and Gross Profit Forecast
12.4.1 China Neutral Alternative Protein Price (USD/Unit) Trend 2021-2026
12.4.2 China Neutral Alternative Protein Gross Profit Trend 2021-2026
13 Conclusion